Correlation Between Oric Pharmaceuticals and HUTCHMED DRC

Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oric Pharmaceuticals and HUTCHMED DRC, you can compare the effects of market volatilities on Oric Pharmaceuticals and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and HUTCHMED DRC.

Diversification Opportunities for Oric Pharmaceuticals and HUTCHMED DRC

-0.74

Correlation Coefficient

Oric Pharmaceuticals  HUTCHMED DRC

Pay attention - limited upside

The 3 months correlation between Oric and HUTCHMED is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and HUTCHMED DRC go up and down completely randomly.

Pair Corralation between Oric Pharmaceuticals and HUTCHMED DRC

Given the investment horizon of 90 days Oric Pharmaceuticals is expected to under-perform the HUTCHMED DRC. In addition to that, Oric Pharmaceuticals is 1.62 times more volatile than HUTCHMED DRC. It trades about -0.02 of its total potential returns per unit of risk. HUTCHMED DRC is currently generating about 0.04 per unit of volatility. If you would invest  1,447  in HUTCHMED DRC on December 25, 2024 and sell it today you would earn a total of  62.00  from holding HUTCHMED DRC or generate 4.28% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Oric Pharmaceuticals  vs.  HUTCHMED DRC

Oric Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Oric Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

HUTCHMED DRC

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in HUTCHMED DRC are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, HUTCHMED DRC may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Oric Pharmaceuticals and HUTCHMED DRC

The main advantage of trading using opposite Oric Pharmaceuticals and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.

The idea behind Oric Pharmaceuticals and HUTCHMED DRC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..